Your calculations assume a known concentration
82 HP 175 IGF-1 LR3 Long R3 IGF-1 extended half-life anabolic research compound ALIASES Long R3 IGF-1, LR3 IGF-1, IGF-1LR3, IGF1 LR3 CLASS Synthetic 83-residue insulin-like growth factor 1 analog FORMULA C400H625N111O115S9 HALF-LIFE ~6 hours (vs ~10 minutes native IGF-1) ROUTES Subcutaneous (research) MECHANISM OF ACTION Long R3 Insulin-like Growth Factor 1 83-residue synthetic analog of native IGF-1 with N-terminal 13-residue extension and Arg substitution at position 3
PrymaLab supplies it as a research-use-only 3ml pen at 5mg/ml
Concerning Symptoms Normal: Mild nausea, feeling full quickly, reduced appetite Concerning: Severe nausea, vomiting, severe abdominal pain, difficulty swallowing Regular Check-ins Your doctor will want to monitor: How youre responding to the medication Any side effects youre experiencing Your weight loss progress Blood sugar levels (if applicable) At Yorktown Health, we provide comprehensive monitoring and support throughout your GLP-1 journey
BPC-157 is a research-stage compound with promising preclinical data but limited human clinical evidence